CONTEXT: Brain metastases are common complications of cancer. Magnetic resonance imaging (MRI), the main diagnostic imaging method in these cases, rarely shows cystic images. CASE REPORT: The patient was a 45-year-old woman who had had severe headache for a month that was refractory to medication, and had previously had breast cancer, which had been treated. The MRI showed the criteria for neurocysticercosis. Since there was no improvement with clinical treatment, we chose to excise the lesions. Histopathological analysis showed an epithelioid malignant neoplasm. CONCLUSION: From immunohistochemical analysis, it was concluded that this was a metastasis of breast carcinoma. Even when the MRI is not characteristic of cerebral metastasis, this hypothesis needs to be ruled out in patients with a previous history of cancer.
INTRODUCTION
Brain metastases are common complications of cancer, and show increasing incidence. They may present clinically as headache, seizures or loss of cognitive or motor function depending on the location of the lesions. 1 Cancers of the breast, lung, kidney, gastrointestinal tract and skin are the commonest causes of cerebral metastases. 1 Magnetic resonance imaging (MRI) is the main diagnostic imaging method. However, metastases rarely show multiple cystic images on MRI. 2 The World Health Organization (WHO) considers that neurocysticercosis is the commonest parasitic disease of the brain; its main manifestation is seizure. 3, 4 The prevalence of neurocysticercosis in Brazil is unknown because of the absence of mandatory reporting in most states.
The seropositivity reaction rate in Brazil is 2.3%, representing 0.3% of all hospitalizations. 5 Neurocysticercosis has been reported in most Brazilian states, with highest prevalence in Paraná, São Paulo, Minas Gerais and Goiás. The costs due to neurocysticercosis treatment and complications in Brazil may reach up to US$ 85 million. 6 We report an unusual case of cystic brain lesions with a radiological diagnosis of neurocysticercosis, but a pathological diagnosis of brain metastases. This case shows the importance of valuing the patient's clinical history in the differential diagnosis of multiple brain lesions.
CASE REPORT
A 45-year-old female was admitted to the Regional Hospital in Presidente Prudente, State of São Paulo, with a complaint of severe headache for a month that was refractory to medication.
She had a history of breast cancer that had been treated with radiotherapy three years before the time of the admission described here.
Computed tomography (CT) showed several hypodense lesions in cerebral parenchyma. MRI showed cystic lesions with an internal nodular structure that was similar to a scolex, thus suggesting the diagnosis of neurocysticercosis. The lesions also had contrast enhancement on the periphery of the cyst that was more intense in the region of mural nodules (Figure 1) .
The patient was treated with albendazole for five days, but without improvement. She then underwent surgery to resect the lesions (Figure 2A ).
The pathological examination revealed an epithelioid malignant neoplasm ( Figure 2B ). Immunohistochemical analysis showed positivity for pan-cytokeratin markers (AE1/AE3) and cytokeratin 7 (CK7) and negativity for cytokeratin 20 (CK20), S-100 protein, estrogen receptor and thyroid transcription factor-1 (TTF-1). From this, the conclusion was a diagnosis of metastatic breast cancer.
The patient underwent radiotherapy, but without improvement. She was admitted to the hospital sometimes with severe headache and vomiting and cerebral edema, but missed the follow-up after one year.
DISCUSSION
Cysts are common findings on MRI and CT brain imaging.
Their histopathological spectrum is broad, and differentiation of these cysts on the basis of imaging findings alone can be problematic. 7, 8 Neurocysticercosis is the most common parasitic disease of the central nervous system (CNS) and should be considered to be a differential diagnosis of brain metastases, especially in patients in endemic countries, because of the similarity of clinical manifestations. 9 We searched in the Li lacs (Literatura Latino- To determine whether a tumor is primary or not, and the primary site of metastatic tumors, immunohistochemical analysis can be used, with specific markers for each tissue and cell. 6 The use of multiple markers may increase the sensitivity, speci-Astrocytic neoplasms and hemangioblastomas (neoplasms 
